valproic acid has been researched along with Atrophy, Muscular, Peroneal in 4 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Memezawa, S | 1 |
| Sato, T | 1 |
| Ochiai, A | 1 |
| Fukawa, M | 1 |
| Sawaguchi, S | 1 |
| Sango, K | 2 |
| Miyamoto, Y | 3 |
| Yamauchi, J | 3 |
| Tatsumi, Y | 1 |
| Matsumoto, N | 1 |
| Iibe, N | 1 |
| Watanabe, N | 1 |
| Torii, T | 2 |
| Homma, K | 1 |
| Sakagami, H | 1 |
| Kusakawa, S | 1 |
| Sanbe, A | 1 |
| Nakamura, K | 1 |
| Takashima, S | 1 |
| Hamasaki, H | 1 |
| Kawaguchi, S | 1 |
| Tanoue, A | 1 |
| Piantino, JA | 1 |
| Torres, A | 1 |
4 other studies available for valproic acid and Atrophy, Muscular, Peroneal
| Article | Year |
|---|---|
The Antiepileptic Valproic Acid Ameliorates Charcot-Marie-Tooth 2W (CMT2W) Disease-Associated HARS1 Mutation-Induced Inhibition of Neuronal Cell Morphological Differentiation Through c-Jun N-terminal Kinase.
Topics: Amino Acyl-tRNA Synthetases; Anticonvulsants; Charcot-Marie-Tooth Disease; Humans; JNK Mitogen-Activ | 2022 |
CMT type 2N disease-associated AARS mutant inhibits neurite growth that can be reversed by valproic acid.
Topics: Alanine-tRNA Ligase; Axons; Charcot-Marie-Tooth Disease; Humans; Mutation; Neurites; Phenotype; Valp | 2019 |
The mood stabilizer valproic acid improves defective neurite formation caused by Charcot-Marie-Tooth disease-associated mutant Rab7 through the JNK signaling pathway.
Topics: Animals; Cell Line, Tumor; Cells, Cultured; Charcot-Marie-Tooth Disease; Humans; JNK Mitogen-Activat | 2010 |
Myoclonic seizures in a patient with Charcot-Marie-tooth disease.
Topics: Anticonvulsants; Carbamazepine; Charcot-Marie-Tooth Disease; Child; Developmental Disabilities; Drug | 2007 |